The mRNA level of Charcot–Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro

References

• Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG. (1993). Molecular cloning and characterization of human eosinophil Charcot–Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 150:456–68.
   Google Scholar
• Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ,Acharya KR. (2002). Charcot–Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J BiolChem 277:14859–68.
   Google Scholar
• Ackerman SJ, Loegering DA, Gleich GJ. (1980). The human eosinophil Charcot–Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. J Immunol 125:2118–26.
   PubMedGoogle Scholar
• Ackerman SJ, Weil GJ, Gleich GJ. (1982). Formation of Charcot–Leyden crystals by human basophils. J Exp Med 155:1597–609.
   PubMed Web of Science ®Google Scholar
• Archer GT, Blackwood A. (1965). Formation of Charcot–Leyden crystals in human eosinophils and basophils and study of the composition of isolated crystals. J Exp Med 122:173–80.
   PubMed Web of Science ®Google Scholar
• Armer RE, Ashton MR, Boyd EA, Brennan CJ, Brookfield FA, Gazi L, Gyles SL, Hay PA, Hunter MG, Middlemiss D, Whittaker M, Xue L, Pettipher R. (2005). Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J Med Chem 48:6174–7.
   PubMed Web of Science ®Google Scholar
• Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. (2001). Prostanoid receptors: subtypes and signaling. Annu Rev PharmacolToxicol 41:661–90.
   Google Scholar
• Bryan SA, Jose PJ, Topping JR, Wilhelm R, Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT, Sabroe I. (2002). Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Am J RespirCrit Care Med 165:1602–9.
   PubMed Web of Science ®Google Scholar
• Bryborn M, Hallden C, Sall T, Cardell LO. (2010). CLC – a novel susceptibility gene for allergic rhinitis? Allergy 65:220–8.
   Google Scholar
• Camby I, Le Mercier M, Lefranc F, Kiss R. (2006). Galectin-1: a small protein with major functions. Glycobiology 16:137R–57R.
   Google Scholar
• Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Ganse E, Mougin B, Pacheco Y. (2008). Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy 63:125–31.
   Google Scholar
• Dor PJ, Ackerman SJ,Gleich GJ. (1984). Charcot–Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases. Am Rev Respir Dis 130:1072–7.
   PubMed Web of Science ®Google Scholar
• Fujishima H, Fukagawa K, Okada N, Takano Y, Tsubota K, Hirai H, Nagata K, Matsumoto K, Saito H. (2005). Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular inflammation in patients with allergic conjunctivitis. Cornea 24:S66–70.
   Google Scholar
• Ge XN, Bahaie NS, Kang BN, Hosseinkhani MR, Ha SG, Frenzel EM, Liu FT, Rao SP, Sriramarao P. (2010). Allergen-induced airway remodeling is impaired in galectin-3-deficient mice. J Immunol 185:1205–14.
   PubMed Web of Science ®Google Scholar
• Ghafouri B, Irander K, Lindbom J, Tagesson C,Lindahl M. (2006). Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J Proteome Res 5:330–8.
   PubMed Web of Science ®Google Scholar
• Hata AN, Breyer RM. (2004). Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. PharmacolTher 103:147–66.
   PubMed Web of Science ®Google Scholar
• Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255–61.
   PubMed Web of Science ®Google Scholar
• Huang JL, Gao PS, Mathias RA, Yao TC, Chen LC, Kuo ML, Hsu SC, Plunkett B, Togias A, Barnes KC, Stellato C, Beaty TH, Huang SK. (2004). Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum Mol Genet 13:2691–7.
   PubMedGoogle Scholar
• Kostenis E, Ulven T. (2006). Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 12:148–58.
   PubMedGoogle Scholar
• Kubach J, Lutter P, Bopp T, Stoll S, Becker C, Huter E, Richter C, Weingarten P, Warger T, Knop J, Mullner S, Wijdenes J, Schild  H, Schmitt E, Jonuleit H. (2007). Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110:1550–8.
   PubMed Web of Science ®Google Scholar
• Luster AD, Tager AM. (2004). T-cell trafficking in asthma: lipid mediators grease the way. Nat Rev Immunol 4:711–24.
   PubMed Web of Science ®Google Scholar
• Martin LM, Peebles RS. (2006). Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think. J Allergy Clin Immunol 117:1036–9.
   Google Scholar
• Mathiesen JM, Christopoulos A, Ulven T, Royer JF, Campillo M, Heinemann A, Pardo L, Kostenis E. (2006). On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. MolPharmacol 69:1441–53.
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima  K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya  S. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013–17.
   PubMed Web of Science ®Google Scholar
• Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98:1942–8.
   PubMed Web of Science ®Google Scholar
• Nagata K, Hirai H. (2003). The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins LeukotEssent Fatty Acids 69:169–77.
   PubMed Web of Science ®Google Scholar
• Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O, Abe H, Tada K, Nakamura M, Sugamura K, Takano S. (1999). Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 162:1278–86.
   PubMed Web of Science ®Google Scholar
• Powell WS. (2003). A novel PGD(2) receptor expressed in eosinophils. Prostaglandins LeukotEssent Fatty Acids 69:179–85.
   Google Scholar
• Sandham DA, Adcock C, Bala K, Barker L, Brown Z, Dubois G, Budd D, Cox B, Fairhurst RA, Furegati M, Leblanc C, Manini J, Profit R, Reilly J, Stringer R, Schmidt A, Turner KL, Watson SJ, Willis J, Williams G, Wilson C. (2009). 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists. Bioorg Med ChemLett 19:4794–8.
   Google Scholar
• Sandham DA, Aldcroft C, Baettig U, Barker L, Beer D, Bhalay G, Brown Z, Dubois G, Budd D, Bidlake L, Campbell E, Cox B, Everatt B, Harrison D, Leblanc CJ, Manini J, Profit R, Stringer  R, Thompson KS, Turner KL, Tweed MF, Walker C, Watson SJ, Whitebread S, Willis J, Williams G, Wilson C. (2007). 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists. Bioorg Med ChemLett 17:4347–50.
   Google Scholar
• Sandig H, Pease JE, Sabroe I. (2007). Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J LeukocBiol 81:372–82.
   Google Scholar
• Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, Yokozeki  H, Hirai  H, Nagata K, Hara T, Utsuyama M, Hirokawa K, Sugamura  K, Nishioka K, Nakamura M. (2006). Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177:2621–9.
   PubMed Web of Science ®Google Scholar
• Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, Metters  KM, O’Neill GP, Gervais FG. (2002). Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 137:1163–72.
   PubMed Web of Science ®Google Scholar
• Schratl P, Royer JF, Kostenis E, Ulven T, Sturm EM, Waldhoer M, Hoefler  G, Schuligoi R, Lippe IT, Peskar BA, Heinemann A. (2007). The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking. J Immunol 179:4792–9.
   PubMedGoogle Scholar
• Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T, Sayama K, Niimi K, Wakaki M, Kagyo J, Ikeda E, Hirai H, Yamaguchi K and Ishizaka A. (2005). Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J PharmacolExpTher, 312: 954–60.
   PubMed Web of Science ®Google Scholar
• Shirasaki H, Kikuchi M, Kanaizumi E, Himi T. (2009). Accumulation of CRTH2-positive leukocytes in human allergic nasal mucosa. Ann Allergy Asthma Immunol, 102: 110–5.
   PubMedGoogle Scholar
• Swaminathan GJ, Leonidas DD, Savage MP, Ackerman SJ, Acharya KR. (1999). Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 a resolution. Biochemistry 38:15406.
   Google Scholar
• Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K. (2004). Effects of prostaglandin D2 on helper T cell functions. BiochemBiophys Res Commun 316:1009–14.
   PubMedGoogle Scholar
• Torres D, Paget C, Fontaine J, Mallevaey T, Matsuoka T, Maruyama T, Narumiya S, Capron M, Gosset P, Faveeuw C, Trottein F. (2008). Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. J Immunol 180:783–92.
   Google Scholar
• Ulven T, Kostenis E. (2005). Minor structural modifications converts the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. J Med Chem 48:897–900.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu Y, Zhao H, Sui H, Liang H, Jiang X. (2009). Genetic variations in chemoattractant receptor expressed on Th2 cells (CRTH2) is associated with asthma susceptibility in Chinese children. MolBiol Rep 36:1549–53.
   PubMedGoogle Scholar
• Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, Pettipher R. (2005). Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 175:6531–6.
   PubMed Web of Science ®Google Scholar